Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
ODDITY Tech $424 million IPO
The shares are listed on the Nasdaq Global Market
Cosan $250 million tender offer
We are advising Cosan on its tender offer for 7% notes due 2027
Korro Bio $117 million private placement
The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics
Toronto-Dominion Bank $3.5 billion notes offering
The investment-grade debt offering consists of three tranches
Keep HK$313 million IPO
The shares are listed on the HKEX
Azul $862 million exchange offers and consent solicitations
The exchange offer included the issuance of the senior secured notes due 2029 and 2030
Toyota $1.5 billion sustainability bond offering
The investment-grade notes are due 2026, 2028 and 2033
SMFG $4.3 billion senior and subordinated notes offerings
We advised SMFG on its SEC-registered offerings of TLAC notes
Deutsche Bank $1.25 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2027
Monitronics International emerges from chapter 11
We advised the ad hoc lender group that negotiated and backstopped the restructuring